Fabino Life Sciences IPO is a fixed price issue of ₹3.24 crores. The issue is entirely a fresh issue of 0.09 crore shares of ₹3.24 crore.
Fabino Life Sciences IPO bidding started from Dec 31, 2021 and ended on Jan 5, 2022. The allotment for Fabino Life Sciences IPO was finalized on Jan 10, 2022. The shares got listed on BSE SME on Jan 13, 2022.
Fabino Life Sciences IPO price is ₹36.00 per share . The lot size for an application is 3,000. The minimum amount of investment required by an individual investor (retail) is ₹1,08,000 (3000 shares). The minimum lot size investment for HNI is 2 lots (6,000 shares), amounting to ₹2,16,000.
Aryaman Financial Services Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The market maker of the company is Aryaman Capital Markets Ltd..
Refer to Fabino Life Sciences IPO RHP for detailed Information.
IPO Date | December 31, 2021 to January 5, 2022 |
Listing Date | January 13, 2022 |
Face Value | ₹10 per share |
Issue Price Band | |
Issue Price Final | ₹36 per share |
Lot Size | 3,000 Shares |
Sale Type | Fresh Capital |
Total Issue Size | 9,00,000 shares (aggregating up to ₹3.24 Cr) |
Reserved for Market Maker | 48,000 shares Aryaman Capital Markets Ltd. (aggregating up to ₹0.1728 Cr) |
Net Offered to Public | 8,52,000 shares (aggregating up to ₹3.07 Cr) |
Issue Type | Fixed Price IPO |
Listing At | BSE SME |
Share Holding Pre Issue | 12,00,000 shares |
Share Holding Post Issue | 21,00,000 shares |
Fabino Life Sciences IPO offers total 9,00,000 shares. Out of which 4,26,000 (47.33%) allocated to NII, 4,26,000 (47.33%) allocated to RII.
Investor Category | Shares Offered |
---|---|
Market Maker Shares Offered | 48,000 (5.33%) |
NII (HNI) Shares Offered | 4,26,000 (47.33%) |
Retail Shares Offered | 4,26,000 (47.33%) |
Total Shares Offered | 9,00,000 (100.00%) |
Fabino Life Sciences IPO opens on December 31, 2021, and closes on January 5, 2022.
IPO Open Date | Fri, Dec 31, 2021 |
IPO Close Date | Wed, Jan 5, 2022 |
Tentative Allotment | Mon, Jan 10, 2022 |
Initiation of Refunds | Tue, Jan 11, 2022 |
Credit of Shares to Demat | Wed, Jan 12, 2022 |
Tentative Listing Date | Thu, Jan 13, 2022 |
Cut-off time for UPI mandate confirmation | 5 PM on Wed, Jan 5, 2022 |
Investors can bid for a minimum of 3,000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 3,000 | ₹1,08,000 |
Retail (Max) | 1 | 3,000 | ₹1,08,000 |
HNI (Min) | 2 | 6,000 | ₹2,16,000 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Fabino Life Sciences is engaged in the manufacturing, marketing, trading, and packing of pharmaceutical and other wellness-focused consumer products. The company's core business is the marketing of pharmaceutical formulation & products in the domestic market through their own distribution network and sales force under their brand name, getting ayurvedic formulations manufactured through loan licensing facilities, packing, labeling, etc. The company export wellness and FMCG products like coffee, malt powder, protein powder, hair shampoo marketed by them.
Currently, the company has over 70 launched and active products available in markets categorized into (i) Allopathic, (ii) Covid 19, (iii) Food & Wellness, (iv) Herbal, (v) Veterinary, (vi) Multi-Vitamin, segments. The shampoo and hair maintenance products from the company are under the brand - Keepshine, while all the others products are marketed under the brand - Fabino. The company has its manufacturing unit in the National Capital Region, India.
Competitive Strengths:
Particulars | For the year/period ended (₹ in Millions) | ||||
---|---|---|---|---|---|
30-Jun-21 | 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | ||
Total Assets | 28.14 | 22.51 | 35.88 | 85.53 | |
Total Revenue | 11.29 | 30.59 | 75.16 | 27.61 | |
Profit After Tax | 0.14 | 0.30 | 0.68 | 0.001 |
The market capitalization of Fabino Life Sciences IPO is ₹7.56 Cr.
Pre IPO | Post IPO | |
---|---|---|
P/E (x) | 133 |
[Dilip Davda] The company has posted erratic financial performance with poor earnings in pandemic periods. The issue is exorbitantly priced based on its latest earnings. Higher promoter’s dilution and lower equity base post IPO are concerned. There is no harm in ignoring this pricy issue. Read detail review...
Listing Date | January 13, 2022 |
BSE Script Code | 543444 |
NSE Symbol | |
ISIN | INE0DRT01018 |
Final Issue Price | ₹36 per share |
BSE Listing Group | MT |
Price Details | BSE SME |
---|---|
Final Issue Price | ₹36.00 |
Open | ₹38.45 |
Low | ₹36.55 |
High | ₹40.35 |
Last Trade | ₹40.35 |
Fabino Life Sciences Ltd.
105, 1st Floor,
Barodia Tower, Plot No 12,
D Block Central Market Prashant Vihar,
New Delhi, New Delhi, 110085
Phone: +91-9883900021
Email: info@fabinolife.com
Website: https://www.fabinolife.com/
Bigshare Services Pvt.Ltd.
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html
Fabino Life Sciences IPO is a SME IPO of 9,00,000 equity shares of the face value of ₹10 aggregating up to ₹3.24 Crores. The issue is priced at ₹36 per share. The minimum order quantity is 3000.
The IPO opens on December 31, 2021, and closes on January 5, 2022.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Fabino Life Sciences IPO using UPI as a payment gateway. Zerodha customers can apply in Fabino Life Sciences IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Fabino Life Sciences IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Fabino Life Sciences IPO opens on December 31, 2021 and closes on January 5, 2022.
Fabino Life Sciences IPO lot size is 3000, and the minimum amount required for application is ₹1,08,000.
You can apply in Fabino Life Sciences IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Fabino Life Sciences IPO will be done on Monday, January 10, 2022, and the allotted shares will be credited to your demat account by Wednesday, January 12, 2022. Check the Fabino Life Sciences IPO allotment status.
The Fabino Life Sciences IPO listing date is on Thursday, January 13, 2022.
Useful Articles